San Diego-based Cellipoint Bioservices, a cell therapy contract development company, is building a manufacturing facility near Houston, according to an Aug. 18 blog post in the Houston Report.
The 76,000-square-foot plant is slated to open in The Woodlands suburb in phases beginning next year and will have manufacturing, development and testing capabilities, according to the post.
"Cellipont is excited to move forward with this next stage of our company's development as a best-in-class cell therapy contract development and manufacturing organization," Cellipoint CEO Deborah Wild stated. "As our client programs advance through the clinic and toward commercialization, we are working diligently to offer them state-of-the-art facilities and capabilities. This site near Houston is an ideal location to serve clients and patients across all of North America, with two major airports and a strong local workforce."